REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Farabi Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Farabi Pharmaceutical Company Public Joint Stock Profile Updated: November 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Farabi Pharmaceutical is a pharmaceutical company specializing in the manufacturing of human medicines, antibiotics, and dietary supplements. The company annually produces capsules, suspensions, and film-coated tablets. Farabi Pharmaceutical claims to export products to over 15 African countries, Central Asia, and neighboring countries.

Legal Address
Km 15, Shiraz Road, P.O. Box: 81655/179
Isfahan; Esfahan; Postal Code: 8179159137

Contact Details: Purchase the Farabi Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.farabipharma.ir

Basic Information
Total Employees:
Purchase the Farabi Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Farabi Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Farabi Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1989
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
51.3%
Purchase this report to view the information.
13.3%
Purchase this report to view the information.
4.9%
Purchase this report to view the information.
1.3%
Purchase this report to view the information.
1.1%
Subsidiaries
Iran Gelatin Capsule Manufacturing Company Public Joint Stock
66.7%
Hejrat Distribution Company Public Joint Stock
25.48%
Company Performance
Financial values in the chart are available after Farabi Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
16.73%▲
Total operating revenue
17.58%▲
Operating profit (EBIT)
5.99%▲
EBITDA
5.4%▲
Net Profit (Loss) for the Period
-12.79%▼
Total assets
44.4%▲
Total equity
42.78%▲
Operating Profit Margin (ROS)
-2.52%▼
Net Profit Margin
-5.36%▼
Return on Equity (ROE)
-19.53%▼
Debt to Equity Ratio
-7.96%▼
Quick Ratio
-0.01%▼
Cash Ratio
-0.07%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo